Close Menu
ABI MS Growth Continues to Slow, Total Revs up 4.3 Percent for Q3
 
Applied Biosystems reported growth of less than 1 percent in its mass spectrometry business this week, while overall revenues rose 4.3 percent for its fiscal third quarter.
 
For the three months ended March 31, ABI’s mass spec revenues rose to $128.5 million, up .94 percent from $127.3 million a year ago. The percentage of total revenues from mass spec sales decreased to 23 percent from 24 percent a year ago.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

In Science this week: three studies from the Ruminant Genome Project, and more.